The latest updates in cyclophotocoagulation

Conferences|GLAUCOMA 360

Shan C. Lin, MD, co-research director, Glaucoma Center of San Francisco, speaks on the highlights from his presentation on the latest in the three forms of cyclophotocoagulation commonly used by clinicians.

See more Glaucoma 360 coverage

Related Videos
ViaLase seeks to disrupt glaucoma treatment paradigm with new femtosecond laser treatment
Contralateral eye study investigates iStent vs Hydrus stent for glaucoma
Robot-assisted micro interventional glaucoma surgery reduces surgeon's tremors
Related Content

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Researchers uncover therapeutic target to aid in glaucoma treatment

March 13th 2023

Exploring the evolution of interventional glaucoma

March 5th 2021

Skye Bioscience receives positive safety review of topical cannabinoid receptor type 1 agonist after second cohort of phase 1 study

February 25th 2023

EnVision Summit 2023: The challenges of tube shunts for glaucoma in pediatric eyes

February 17th 2023

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Researchers uncover therapeutic target to aid in glaucoma treatment

March 13th 2023

Exploring the evolution of interventional glaucoma

March 5th 2021

Skye Bioscience receives positive safety review of topical cannabinoid receptor type 1 agonist after second cohort of phase 1 study

February 25th 2023

EnVision Summit 2023: The challenges of tube shunts for glaucoma in pediatric eyes

February 17th 2023

The challenges of tube shunts in pediatric glaucoma surgery

March 20th 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

Researchers uncover therapeutic target to aid in glaucoma treatment

March 13th 2023

Exploring the evolution of interventional glaucoma

March 5th 2021

Skye Bioscience receives positive safety review of topical cannabinoid receptor type 1 agonist after second cohort of phase 1 study

February 25th 2023

EnVision Summit 2023: The challenges of tube shunts for glaucoma in pediatric eyes

February 17th 2023
© 2023 MJH Life Sciences

All rights reserved.